Coronavirus (COVID-19) – Use of Paxlovid (nirmatrelvir + ritonavir) in residential aged care

This fact sheet outlines the key considerations of introducing Paxlovid® (nirmatrelvir + ritonavir) into residential aged care clinical practices.

Coronavirus (COVID-19) – Use of Paxlovid® (nirmatrelvir + ritonavir) in residential aged care

About this resource

Publication date:
Publication type:
Fact sheet
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.